Additional file 1 of Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study
Additional file 1. Whole genome sequencing data of the 31 SARS-CoV-2 samples in our study.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Dataset |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Shimazu, Haruka Wada, Daiki Maruyama, Shuhei Inoue, Akira Kashihara, Masami Yoshihara, Tomoyuki Saito, Fukuki Yoshiya, Kazuhisa Nakamori, Yasushi Kuwagata, Yasuyuki |
| description | Additional file 1. Whole genome sequencing data of the 31 SARS-CoV-2 samples in our study. |
| doi_str_mv | 10.6084/m9.figshare.24540686 |
| format | Dataset |
| fullrecord | <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_24540686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_24540686</sourcerecordid><originalsourceid>FETCH-LOGICAL-d916-7142efddb4d401262d70582d9b3eed0a35af3e8fe8ab9939efa7de233d78928d3</originalsourceid><addsrcrecordid>eNo1kE1OwzAQhbNhgQo3YOELpCRxmsTsqog_qRISrdhGTmbcjhQ7ke0Uek1OhC1gNT_63rzRS5K7PFtXWVPea7FWdHQnaXFdlJsyq5rqOvneApCnyciRKRqR5WxSrB3J0BBW-DWjJTQDxrW3KL1G4-NAWi9mGiY920mTQ2BkgM4Eixwd-yR_YkHryPko2G_f92k7faRFwBQO0ZL1MspCA3Y5MosRltFLL15GwjFAj1aTCVx_YUc0wWtgMrx7CfQDk4Fwg6XZ0xmZ8wtcbpIrFV7A27-6Sg5Pj4f2Jd29Pb-2210KIq_SOi8LVAB9CWWWF1UBdbZpChA9R4RM8o1UHBuFjeyF4AKVrAELzqFuRNEAXyXl71mQXg7ksZstaWkvXZ51MfFOi-4_8e4_cf4Dj3qEDQ</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Additional file 1 of Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study</title><source>DataCite</source><creator>Shimazu, Haruka ; Wada, Daiki ; Maruyama, Shuhei ; Inoue, Akira ; Kashihara, Masami ; Yoshihara, Tomoyuki ; Saito, Fukuki ; Yoshiya, Kazuhisa ; Nakamori, Yasushi ; Kuwagata, Yasuyuki</creator><creatorcontrib>Shimazu, Haruka ; Wada, Daiki ; Maruyama, Shuhei ; Inoue, Akira ; Kashihara, Masami ; Yoshihara, Tomoyuki ; Saito, Fukuki ; Yoshiya, Kazuhisa ; Nakamori, Yasushi ; Kuwagata, Yasuyuki</creatorcontrib><description>Additional file 1. Whole genome sequencing data of the 31 SARS-CoV-2 samples in our study.</description><identifier>DOI: 10.6084/m9.figshare.24540686</identifier><language>eng</language><publisher>figshare</publisher><subject>Biotechnology ; Cancer ; FOS: Biological sciences ; FOS: Health sciences ; Genetics ; Hematology ; Infectious Diseases ; Medicine ; Mental Health ; Microbiology ; Pharmacology ; Virology</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,1894</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.24540686$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Shimazu, Haruka</creatorcontrib><creatorcontrib>Wada, Daiki</creatorcontrib><creatorcontrib>Maruyama, Shuhei</creatorcontrib><creatorcontrib>Inoue, Akira</creatorcontrib><creatorcontrib>Kashihara, Masami</creatorcontrib><creatorcontrib>Yoshihara, Tomoyuki</creatorcontrib><creatorcontrib>Saito, Fukuki</creatorcontrib><creatorcontrib>Yoshiya, Kazuhisa</creatorcontrib><creatorcontrib>Nakamori, Yasushi</creatorcontrib><creatorcontrib>Kuwagata, Yasuyuki</creatorcontrib><title>Additional file 1 of Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study</title><description>Additional file 1. Whole genome sequencing data of the 31 SARS-CoV-2 samples in our study.</description><subject>Biotechnology</subject><subject>Cancer</subject><subject>FOS: Biological sciences</subject><subject>FOS: Health sciences</subject><subject>Genetics</subject><subject>Hematology</subject><subject>Infectious Diseases</subject><subject>Medicine</subject><subject>Mental Health</subject><subject>Microbiology</subject><subject>Pharmacology</subject><subject>Virology</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2023</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNo1kE1OwzAQhbNhgQo3YOELpCRxmsTsqog_qRISrdhGTmbcjhQ7ke0Uek1OhC1gNT_63rzRS5K7PFtXWVPea7FWdHQnaXFdlJsyq5rqOvneApCnyciRKRqR5WxSrB3J0BBW-DWjJTQDxrW3KL1G4-NAWi9mGiY920mTQ2BkgM4Eixwd-yR_YkHryPko2G_f92k7faRFwBQO0ZL1MspCA3Y5MosRltFLL15GwjFAj1aTCVx_YUc0wWtgMrx7CfQDk4Fwg6XZ0xmZ8wtcbpIrFV7A27-6Sg5Pj4f2Jd29Pb-2210KIq_SOi8LVAB9CWWWF1UBdbZpChA9R4RM8o1UHBuFjeyF4AKVrAELzqFuRNEAXyXl71mQXg7ksZstaWkvXZ51MfFOi-4_8e4_cf4Dj3qEDQ</recordid><startdate>20231110</startdate><enddate>20231110</enddate><creator>Shimazu, Haruka</creator><creator>Wada, Daiki</creator><creator>Maruyama, Shuhei</creator><creator>Inoue, Akira</creator><creator>Kashihara, Masami</creator><creator>Yoshihara, Tomoyuki</creator><creator>Saito, Fukuki</creator><creator>Yoshiya, Kazuhisa</creator><creator>Nakamori, Yasushi</creator><creator>Kuwagata, Yasuyuki</creator><general>figshare</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20231110</creationdate><title>Additional file 1 of Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study</title><author>Shimazu, Haruka ; Wada, Daiki ; Maruyama, Shuhei ; Inoue, Akira ; Kashihara, Masami ; Yoshihara, Tomoyuki ; Saito, Fukuki ; Yoshiya, Kazuhisa ; Nakamori, Yasushi ; Kuwagata, Yasuyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d916-7142efddb4d401262d70582d9b3eed0a35af3e8fe8ab9939efa7de233d78928d3</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biotechnology</topic><topic>Cancer</topic><topic>FOS: Biological sciences</topic><topic>FOS: Health sciences</topic><topic>Genetics</topic><topic>Hematology</topic><topic>Infectious Diseases</topic><topic>Medicine</topic><topic>Mental Health</topic><topic>Microbiology</topic><topic>Pharmacology</topic><topic>Virology</topic><toplevel>online_resources</toplevel><creatorcontrib>Shimazu, Haruka</creatorcontrib><creatorcontrib>Wada, Daiki</creatorcontrib><creatorcontrib>Maruyama, Shuhei</creatorcontrib><creatorcontrib>Inoue, Akira</creatorcontrib><creatorcontrib>Kashihara, Masami</creatorcontrib><creatorcontrib>Yoshihara, Tomoyuki</creatorcontrib><creatorcontrib>Saito, Fukuki</creatorcontrib><creatorcontrib>Yoshiya, Kazuhisa</creatorcontrib><creatorcontrib>Nakamori, Yasushi</creatorcontrib><creatorcontrib>Kuwagata, Yasuyuki</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Shimazu, Haruka</au><au>Wada, Daiki</au><au>Maruyama, Shuhei</au><au>Inoue, Akira</au><au>Kashihara, Masami</au><au>Yoshihara, Tomoyuki</au><au>Saito, Fukuki</au><au>Yoshiya, Kazuhisa</au><au>Nakamori, Yasushi</au><au>Kuwagata, Yasuyuki</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Additional file 1 of Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study</title><date>2023-11-10</date><risdate>2023</risdate><abstract>Additional file 1. Whole genome sequencing data of the 31 SARS-CoV-2 samples in our study.</abstract><pub>figshare</pub><doi>10.6084/m9.figshare.24540686</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | DOI: 10.6084/m9.figshare.24540686 |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_datacite_primary_10_6084_m9_figshare_24540686 |
| source | DataCite |
| subjects | Biotechnology Cancer FOS: Biological sciences FOS: Health sciences Genetics Hematology Infectious Diseases Medicine Mental Health Microbiology Pharmacology Virology |
| title | Additional file 1 of Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T05%3A04%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Shimazu,%20Haruka&rft.date=2023-11-10&rft_id=info:doi/10.6084/m9.figshare.24540686&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_24540686%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |